ABSTRACT Neisseria gonorrhoeae is the causative agent of gonorrhea and was identified by the World Health Organization as an urgent public health threat due to emerging antibiotic resistance. Here, we report 13 draft genome sequences of N. gonorrhoeae isolates derived from two epidemiologically linked cases from Austria.
N
eisseria gonorrhoeae is the etiological agent of the sexually transmitted disease gonorrhea, and it poses a public health threat due to the emergence of multidrugresistant strains (1) (2) (3) (4) . Whole-genome sequencing is considered a powerful strategy to elucidate chains of transmission (5) . Here, we announce the draft genome sequences of 13 epidemiologically linked N. gonorrhoeae isolates.
Two vaginal swabs, taken from a 3-year-old girl on 10 January 2018, and her rectal swab, gained on 13 January 2018, yielded N. gonorrhoeae colonies on Chocolat PolyViteX VCAT3 agar plates (bioMérieux, Marcy-l'Étoile, France). A 46-year-old male household member was sampled on 13 January 2018, and N. gonorrhoeae colonies grew from a rectal swab. Eight single colonies from the child and five from the adult were further analyzed.
For each isolate, antimicrobial susceptibility was determined according to the EUCAST recommendations for gonococci (6) . All 13 isolates showed resistance to penicillin G (median MIC, 6 g/ml; range, 1.5 to 32 g/ml), tetracycline (median MIC, 24 g/ml; range, 24 to 64 g/ml), and ciprofloxacin (median MIC, 0.75 g/ml; range, 0.5 to 1.5 g/ml), but were susceptible to ceftriaxone, cefixime, and azithromycin.
Genomic DNA isolation, whole-genome sequencing, assembly, and contig filtering were performed as described previously (7). Paired-end sequencing (2 ϫ 300 bp) generated 348,172 to 847,328 reads, with a mean coverage of 41-to 89-fold. The NCBI Prokaryotic Genome Automatic Annotation Pipeline identified 2,654 to 2,720 genes, 2,604 to 2,664 coding sequences, 273 to 305 pseudogenes, 3 to 6 rRNA genes, and 47 to 51 tRNA genes.
Antimicrobial resistance genes were identified using the Comprehensive Antibiotic Resistance Database (CARD) (8). All 13 isolates had gyrA, N. meningitidis PBP2 and rpsJ, and the efflux genes farA, farB, macA, macB, mtrC, mtrD, and mtrR. In addition, bla TEM-1 was detected in three child and three household member isolates. Three isolates from the child and one from the household member carried bla TEM-90 . One child isolate had bla , and another one carried bla TEM-150 plus the efflux gene patA.
All 13 isolates belonged to multilocus sequence type (MLST) 1588 (ST1588). An ad hoc core genome MLST (cgMLST) scheme comprising 1,524 targets was established using strain MS11 (ATCC BAA-1833) as a reference. Child isolates differed by zero to three alleles and household member isolates by zero to one alleles; the maximum interindividual variability of the isolates was five allelic differences. In the course of comparison with the Austrian Agency for Health and Food Safety (AGES) N. gonor-rhoeae whole-genome database (currently covering 452 isolates from the years 2014 to 2018), all but one isolate differed by at least 303 alleles. An isolate gained in 2016 (strain 980016-16) from a urethral swab of an epidemiologically unrelated 32-year-old male patient, registered in the same Austrian province as the two described case patients, showed a six-allele difference. From these results, we propose a complex-type threshold of a maximum of five allelic differences for direct transmission events of N. gonorrhoeae. Our findings underline the considerable potential of whole-genome sequencing (WGS) to document chains of transmission.
Accession number(s).
This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers shown in Table 1 . The versions described in this paper are the first versions.
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